Cite
HARVARD Citation
Patel, A. et al. (2020). Clinical outcomes of IDH2‐mutated advanced‐phase Ph‐negative myeloproliferative neoplasms treated with enasidenib. British journal of haematology. pp. e48-e51. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Patel, A. et al. (2020). Clinical outcomes of IDH2‐mutated advanced‐phase Ph‐negative myeloproliferative neoplasms treated with enasidenib. British journal of haematology. pp. e48-e51. [Online].